Literature DB >> 14751776

Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques.

Claire E Shepherd1, Gillian C Gregory, James C Vickers, William S Brooks, John B J Kwok, Peter R Schofield, Jillian J Kril, Glenda M Halliday.   

Abstract

Mutations in presenilin-1 (PS-1) account for the majority of familial Alzheimer's disease (AD). While increasing Abeta42 is one mechanism whereby PS-1 mutations are thought to exert their pathogenic effect, little is known about the role of tau in PS-1 AD. This study compares staining (AT8 and tau-2), morphology and quantity of tau-immunoreactive cortical plaques in six PS-1 and five sporadic AD cases. The densities of tau-positive plaques differentiated PS-1 from sporadic AD cases. All PS-1 cases demonstrated a greater than 6-fold increase in tau-2-positive plaques. In PS-1 cases with mutations in exons 5 and 6, there was an increase in classical AD plaques containing hyperphosphorylated tau (AT8- and tau 2-positive). However, cases with exon 8 and 9 mutations had numerous cotton wool plaques containing nonhyperphosphorylated tau (tau-2-positive, AT8-negative). These findings suggest that PS-1 mutations increase tau deposition while mutation-specific cellular responses determine phosphorylation events and may influence cell death mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751776     DOI: 10.1016/j.nbd.2003.10.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  10 in total

Review 1.  The genetics and neuropathology of Alzheimer's disease.

Authors:  Gerard D Schellenberg; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2012-05-23       Impact factor: 17.088

2.  Difficult case of a rare form of familial Alzheimer's disease with PSEN1 P117L mutation.

Authors:  Ana Luísa Rocha; Andreia Costa; Maria Carolina Garrett; Joana Meireles
Journal:  BMJ Case Rep       Date:  2018-12-13

3.  Presenilin-1 regulates the expression of p62 to govern p62-dependent tau degradation.

Authors:  Ying-Tsen Tung; Bo-Jeng Wang; Wen-Ming Hsu; Ming-Kuan Hu; Guor Mour Her; Wei-Pang Huang; Yung-Feng Liao
Journal:  Mol Neurobiol       Date:  2013-06-23       Impact factor: 5.590

Review 4.  The Role of Presenilin in Protein Trafficking and Degradation-Implications for Metal Homeostasis.

Authors:  M A Greenough
Journal:  J Mol Neurosci       Date:  2016-08-25       Impact factor: 3.444

5.  Familial dementia with frontotemporal features associated with M146V presenilin-1 mutation.

Authors:  Miguel A Riudavets; Leonardo Bartoloni; Juan C Troncoso; Olga Pletnikova; Peter St George-Hyslop; Marcelo Schultz; Gustavo Sevlever; Ricardo F Allegri
Journal:  Brain Pathol       Date:  2013-04-25       Impact factor: 6.508

6.  The presenilin-1 ΔE9 mutation results in reduced γ-secretase activity, but not total loss of PS1 function, in isogenic human stem cells.

Authors:  Grace Woodruff; Jessica E Young; Fernando J Martinez; Floyd Buen; Athurva Gore; Jennifer Kinaga; Zhe Li; Shauna H Yuan; Kun Zhang; Lawrence S B Goldstein
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

7.  Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2.

Authors:  Ruiben Feng; Huimin Wang; Jianlin Wang; David Shrom; Xuemei Zeng; Joe Z Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

8.  The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis".

Authors:  R A Armstrong
Journal:  Int J Alzheimers Dis       Date:  2011-02-07

9.  Patient-Derived Fibroblasts With Presenilin-1 Mutations, That Model Aspects of Alzheimer's Disease Pathology, Constitute a Potential Object for Early Diagnosis.

Authors:  Gustavo Lopez-Toledo; Maria-Del-Carmen Silva-Lucero; Jorge Herrera-Díaz; David-Erasmo García; José-Antonio Arias-Montaño; Maria-Del-Carmen Cardenas-Aguayo
Journal:  Front Aging Neurosci       Date:  2022-07-01       Impact factor: 5.702

10.  Factors determining disease duration in Alzheimer's disease: a postmortem study of 103 cases using the Kaplan-Meier estimator and Cox regression.

Authors:  R A Armstrong
Journal:  Biomed Res Int       Date:  2014-01-22       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.